Log In
BCIQ
Print this Print this
 

4-OHT, Afimoxifene gel

  Manage Alerts
Collapse Summary General Information
Company Besins Healthcare S.A.
DescriptionAfimoxifene (4-OHT) gel, an active metabolite of tamoxifen
Molecular Target Estrogen receptor 1 (ESR1)
Mechanism of ActionEstrogen receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationBreast cancer
Indication DetailsTreat ductal carcinoma in situ (DCIS) of the breast
Regulatory Designation
PartnerAtossa Genetics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/18/2015

Undisclosed

0

Undisclosed

Get a free BioCentury trial today